[go: up one dir, main page]

WO2000023061A3 - Solution et methode d'irrigation destinees a l'inhibition d'une douleur et d'une inflammation - Google Patents

Solution et methode d'irrigation destinees a l'inhibition d'une douleur et d'une inflammation Download PDF

Info

Publication number
WO2000023061A3
WO2000023061A3 PCT/US1999/024557 US9924557W WO0023061A3 WO 2000023061 A3 WO2000023061 A3 WO 2000023061A3 US 9924557 W US9924557 W US 9924557W WO 0023061 A3 WO0023061 A3 WO 0023061A3
Authority
WO
WIPO (PCT)
Prior art keywords
antagonist
pain
solution
inflammation
inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1999/024557
Other languages
English (en)
Other versions
WO2000023061A2 (fr
Inventor
Gregory A Demopulos
Pamela P Palmer
Jeffrey M Herz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Omeros Corp
Original Assignee
Omeros Medical Systems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Omeros Medical Systems Inc filed Critical Omeros Medical Systems Inc
Priority to AU12148/00A priority Critical patent/AU1214800A/en
Publication of WO2000023061A2 publication Critical patent/WO2000023061A2/fr
Publication of WO2000023061A3 publication Critical patent/WO2000023061A3/fr
Priority to US09/839,633 priority patent/US20020028798A1/en
Priority to US09/839,633 priority patent/US7091181B2/en
Anticipated expiration legal-status Critical
Priority to US11/410,406 priority patent/US20060205657A1/en
Priority to US11/410,407 priority patent/US20060205658A1/en
Priority to US11/409,919 priority patent/US20060229588A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne une méthode et une solution d'inhibition périopératoire de différentes sortes de manifestations de douleur et d'inflammation de plaies suite à des interventions chirurgicales y compris des interventions buccales/dentaires. La solution comprend de préférence au moins un inhibiteur de COX-2 et, éventuellement, plusieurs agents supplémentaires d'inhibition de douleur et d'inflammation dans des concentrations diluées dans un excipient physiologique tel qu'un soluté salin ou un soluté lactate de Ringer. On applique la solution par irrigation continue d'une plaie pendant une intervention chirurgicale pour favoriser une inhibition préventive de la douleur et éviter des effets secondaires indésirables associés à l'administration par voie orale, intramusculaire, sous-cutanée ou intraveineuse de doses plus importantes de ces agents. De préférence, une solution d'inhibition de douleur et d'inflammation comprend un inhibiteur de COX-2, un antagoniste de sérotonine2, un antagoniste de sérotonine3, un antagoniste d'histamine, un agoniste de sérotonine, un inhibiteur de cyclooxygénase, un antagoniste de neurokinine1, un antagoniste de neurokinine2, un antagoniste de purinocepteur, un élément d'ouverture du canal potassique sensible à l'ATP, un antagoniste du canal potassique, un antagoniste de bradykinine1, un antagoniste de bradikynine2 et un agoniste d'ν-opioïde.
PCT/US1999/024557 1994-12-12 1999-10-20 Solution et methode d'irrigation destinees a l'inhibition d'une douleur et d'une inflammation Ceased WO2000023061A2 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
AU12148/00A AU1214800A (en) 1998-10-21 1999-10-20 Irrigation solution and method for inhibition of pain and inflammation
US09/839,633 US20020028798A1 (en) 1995-12-12 2001-04-20 Irrigation solution and method for inhibition of pain and inflammation
US09/839,633 US7091181B2 (en) 1994-12-12 2001-04-20 Method of inhibition of pain and inflammation during surgery comprising administration of soluble TNF receptors
US11/410,406 US20060205657A1 (en) 1994-12-12 2006-04-24 Irrigation solution and method for inhibition of pain and inflammation
US11/410,407 US20060205658A1 (en) 1994-12-12 2006-04-24 Irrigation solution and method for inhibition of pain and inflammation
US11/409,919 US20060229588A1 (en) 1994-12-12 2006-04-24 Irrigation solution and method for inhibition of pain and inflammation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10516698P 1998-10-21 1998-10-21
US60/105,166 1998-10-21

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09/072,913 Continuation-In-Part US6261279B1 (en) 1994-12-12 1998-05-04 Surgical irrigation solution and method for inhibition of pain and inflammation

Related Child Applications (5)

Application Number Title Priority Date Filing Date
PCT/US1999/024558 Continuation-In-Part WO2000023062A2 (fr) 1994-12-12 1999-10-20 Solution et methode d'irrigation destinees a l'inhibition d'une douleur et d'une inflammation
US09/839,633 Continuation-In-Part US20020028798A1 (en) 1994-12-12 2001-04-20 Irrigation solution and method for inhibition of pain and inflammation
US11/409,919 Continuation-In-Part US20060229588A1 (en) 1994-12-12 2006-04-24 Irrigation solution and method for inhibition of pain and inflammation
US11/410,407 Continuation-In-Part US20060205658A1 (en) 1994-12-12 2006-04-24 Irrigation solution and method for inhibition of pain and inflammation
US11/410,406 Continuation-In-Part US20060205657A1 (en) 1994-12-12 2006-04-24 Irrigation solution and method for inhibition of pain and inflammation

Publications (2)

Publication Number Publication Date
WO2000023061A2 WO2000023061A2 (fr) 2000-04-27
WO2000023061A3 true WO2000023061A3 (fr) 2000-11-16

Family

ID=22304411

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/024557 Ceased WO2000023061A2 (fr) 1994-12-12 1999-10-20 Solution et methode d'irrigation destinees a l'inhibition d'une douleur et d'une inflammation

Country Status (2)

Country Link
AU (1) AU1214800A (fr)
WO (1) WO2000023061A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001259974A1 (en) * 2000-05-15 2001-11-26 Merck Frosst Canada & Co Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor
DK1534313T3 (da) 2002-07-30 2013-02-04 Omeros Corp Oftalmologiske irrigationsopløsninger og fremgangsmåde
KR20090112722A (ko) 2007-01-24 2009-10-28 글락소 그룹 리미티드 3,5-디아미노-6-(2,3-디클로로페닐)-1,2,4-트리아진 또는 ｒ(-)-2,4-디아미노-5-(2,3-디클로로페닐)-6-플루오로메틸 피리미딘 및 ｎｋ1을 포함하는 제약 조성물
AU2013201465B2 (en) 2012-10-24 2016-03-03 Rayner Intraocular Lenses Limited Stable preservative-free mydriatic and anti-inflammatory solutions for injection
TWI705812B (zh) 2014-12-01 2020-10-01 奥默羅斯公司 用於抑制術後眼睛炎性病況的抗炎和散瞳前房溶液

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5373022A (en) * 1991-03-04 1994-12-13 The Warner-Lambert Company Salts/ion pairs of non-steroidal anti-inflammatory drugs in various dosage forms
US5820583A (en) * 1995-12-12 1998-10-13 Omeros Medical Systems, Inc. Surgical irrigation solution and method for inhibition of pain and inflammation

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5373022A (en) * 1991-03-04 1994-12-13 The Warner-Lambert Company Salts/ion pairs of non-steroidal anti-inflammatory drugs in various dosage forms
US5820583A (en) * 1995-12-12 1998-10-13 Omeros Medical Systems, Inc. Surgical irrigation solution and method for inhibition of pain and inflammation

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
BURITOVA JAROSLAVA; CHAPMAN VICTORIA; HONORE PRISCA; BESSON JEAN-MARIE: "Selective cyclooxygenase-2 inhibition reduces carrageenan oedema and associated spinal c-Fos expression in the rat.", BRAIN RESEARCH, vol. 715, no. 1-2, 1996, pages 217 - 220, XP000905607 *
ENGELHARDT G: "Pharmacology of meloxicam, a new non-steroidal anti-inflammatory drug with an improved safety profile through preferential inhibition of COX-2.", BRITISH JOURNAL OF RHEUMATOLOGY, vol. 35, no. suppl. 1, 1996, pages 4 - 12, XP000905630 *
HAY CATRIONA; DE BELLEROCHE JACQUELINE: "Carrageenan-induced hyperalgesia is associated with increased cyclo-oxygenase-2 expression in spinal cord.", NEUROREPORT, vol. 8, no. 5, 1997, pages 1249 - 1251, XP000905625 *
JOSHI G.P.: "Postoperative pain management.", INTERNATIONAL ANESTHESIOLOGY CLINICS, (1994) 32/3 (113-126)., XP000905593 *
MEHLISCH D R; HUBBARD R C; ISAKSON P; KARIM A; WEAVER M; MILLS S: "Analgesic efficacy and plasma levels of a highly selective inhibitor of COX-2 (SC-58635;SC) in patients with post-surgical dental pain.", CLINICAL PHARMACOLOGY & THERAPEUTICS, vol. 61, no. 2, 1997, pages 195, XP000905616 *
OSIPOVA N A: "[Antinociceptive components of general anesthesia and postoperative analgesia]. Antinotsitseptivnye komponenty obschchei anestezii i posleoperatsionnoi analgezii.", ANESTEZIOLOGIIA I REANIMATOLOGIIA, (1998 SEP-OCT) (5) 11-5. REF: 21, XP000905655 *
REYNOLDS J.: "Martindale - The Extra Pharmacopoeia Edition 31", 1996, ROYAL PHARMACEUTICAL SOCIETY, LONDON GB, XP002137139, 224540 *
SCHWEIZER A; BROM R; WIESENBERG-BOETTCHER I: "INHIBITION OF INTERLEUKIN-1 IL-1 ENHANCED PAIN REFLEXES IN THE RABBIT BY CGP-28238", AGENTS AND ACTIONS, vol. 32, no. 1-2, 1991, pages 67 - 69, XP000905639 *
SEIBERT KAREN; ZHANG YAN; LEAHY KATHLEEN; HAUSER SCOTT; MASFERRER JAIME; PERKINS WILLIAM; LEE LEN; ISAKSON PETER: "Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 91, no. 25, 1994, pages 12013 - 12017, XP000604765 *
SOUTER A J ET AL: "CONTROVERSIES IN THE PERIOPERATIVE USE OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS", ANESTHESIA AND ANALGESIA, (DEC 1994) VOL. 79, NO. 6, PP. 1178-1190. ISSN: 0003-2999., UNIV TEXAS, SW MED CTR, DEPT ANESTHESIOL & PAIN MANAGEMENT, 5323 HARRY HINES BLVD, DALLAS, TX, 75235 (Reprint);UNIV TEXAS, SW MED CTR, DEPT ANESTHESIOL & PAIN MANAGEMENT, DALLAS, TX, 75235, XP000905591 *

Also Published As

Publication number Publication date
AU1214800A (en) 2000-05-08
WO2000023061A2 (fr) 2000-04-27

Similar Documents

Publication Publication Date Title
WO2001007067A3 (fr) Solutions et procedes permettant d'inhiber la douleur, les inflammations et la degradation des cartilages
AU6397496A (en) Vascular irrigation solution and method for inhibition of pain, inflammation, spasm and restenosis
CA2206119A1 (fr) Solution d'irrigation et procede d'inhibition de la douleur, de l'inflammation et des spasmes
WO2000023062A3 (fr) Solution et methode d'irrigation destinees a l'inhibition d'une douleur et d'une inflammation
CA2105652A1 (fr) Reduction de la cicatrisation en utilisant des anticorps a facteurs de croissance
WO2005044194A3 (fr) Traitement ou prevention de la neoplasie a l'aide d'un inhibiteur de la proteine hsp90
WO2005048942A3 (fr) Polytherapie contenant un inhibiteur cox-2 et un agent antineoplasique
NZ515567A (en) Method for treating chronic pain using MEK inhibitors
WO2000025745A3 (fr) Solution d'irrigation et methode pour l'inhibition de la douleur et de l'inflammation
BR0113749A (pt) Métodos para inibir a diminuição no fluxo de droga transdérmica por inibição do fechamento das vias
AU3451797A (en) Compositions for the treatment of peripheral neuropathies containing antidepressants and/or monoamine oxidase inhibitors and/or vitamin b12 and/or precursors or inducers of a neurotransmitter
AP1780A (en) Use of cox-2 inhibitors for preventing immunodeficiency.
WO2000023061A3 (fr) Solution et methode d'irrigation destinees a l'inhibition d'une douleur et d'une inflammation
WO2000023066A3 (fr) Solution d'irrigation et procede d'inhibition de la douleur et de l'inflammation
CA2179015A1 (fr) Utilisation de bis(amidinobenzimidazoles) dans la fabrication de medicaments destines a inhiber l'integrase retrovirale
RU94044356A (ru) Применение 2-фенил-3-ароилбензотиофенов для увеличения экспрессии тромбомодулина для ингибирования тромботического расстройства, для увеличения активации протеина с
EP1563838A3 (fr) Solution d'irrigation et méthodes pour inhiber la douleur et l'inflammation
WO2002085292A3 (fr) Procede ameliore de traitement de manifestations aberrantes du tissu fibreux avec des preparations a base d'agent bloquant topique des canaux de calcium et composition amelioree utilisee dans ce traitement et son procede de fabrication ameliore
WO2004069029A3 (fr) Prevention des adherences chirurgicales a l'aide d'inhibiteurs selectifs du cox-2
EP1051993A3 (fr) Agonistes de récepteur de 5HT 1 et soit un inhibiteur de la cyclooxygénase-2 soit un anti-inflammatoire non stéroidien pour le traitment de la migraine
WO2000032155A3 (fr) Compositions pour soins de la peau renfermant des sels de zinc et des retinoides
WO2003093415A3 (fr) Methodes utilisees dans le traitement et la prevention d'une infection par vih
MX2025004372A (es) Combinacion para su uso en el tratamiento de canceres
CA2251353A1 (fr) Dispositif pour administration transdermique de composes d'azapirone
WO2004035030A3 (fr) Composes organiques

Legal Events

Date Code Title Description
ENP Entry into the national phase

Ref country code: AU

Ref document number: 2000 12148

Kind code of ref document: A

Format of ref document f/p: F

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
WWE Wipo information: entry into national phase

Ref document number: 11410407

Country of ref document: US

Ref document number: 11409919

Country of ref document: US

Ref document number: 11410406

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 11410407

Country of ref document: US

Ref document number: 11410406

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 11409919

Country of ref document: US